Status: Recruiting
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
A prospective observational trial of patients with metastatic cancer of various entities which aims at both clarifying the significance of liquid biopsy and establishing a foundation for translational research.
Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital AugsburgUpdated: Jul 30, 2026Locations: 1
Eligibility criteria
Written informed consent [+8]
Psychological condition that would preclude informed consent [+1]